Equity Profile

STE

STERIS plc

Health CareHealth Care Equipment$23.0B

Aug5Wed

Pre-Earnings Brief

UpcomingQ1-2027After Close5:00 PM EDT

Company Snapshot

STERIS plc is a leading provider of health care equipment and services, focusing on sterilization and infection prevention. Operating in the health care sector, the company plays a crucial role in ensuring patient safety and improving outcomes in medical environments.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

$2.85

Revenue Growth

Revenue growth reflects the company's ability to increase sales and expand its market presence, which is vital for long-term success.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

STE Q1-2027 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+1.57%

Avg Stock Reaction

-0.34%

Last Quarter Recap

In the last quarter, STERIS reported an EPS of $2.83, slightly missing the estimate of $2.85. The stock reacted negatively, dropping 2.70% the following day.

Management Promises & Guidance

Focus on improving product offerings and customer service.
Commitment to expanding into new markets.
Plans to enhance operational efficiency.

Expectations

Wall Street Expectations

Overall, analysts are cautious ahead of STERIS's earnings report, given the recent EPS miss and mixed market conditions.

Bull Case

If STERIS can show strong revenue growth and improved margins, it could signal a recovery and boost investor confidence.

Bear Case

A continued trend of missing earnings estimates or weak guidance could lead to further declines in stock price.

Key Metrics to Watch

Earnings Per Share (EPS)

$2.85

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

Revenue Growth

N/A

Revenue growth reflects the company's ability to increase sales and expand its market presence, which is vital for long-term success.

Operating Margin

N/A

Operating margin shows how efficiently the company is managing its costs relative to its revenue, an important factor for profitability.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q1-2027?

The EPS figure is crucial for assessing the company's profitability and will heavily influence market sentiment.

How is STERIS addressing recent operational challenges?

Investors will want to know how management plans to improve efficiency and growth, especially after a recent earnings miss.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate STERIS's potential for recovery, given its recent investments in new product lines that could drive future growth.

Supporting Evidence

Options are pricing a significant move, suggesting that investors expect a more volatile reaction than historical averages.

The company's strong track record of innovation could lead to better-than-expected results despite recent challenges.

Key Risk

If STERIS can demonstrate improved operational efficiency and revenue growth, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether STERIS can recover from recent earnings misses and improve its financial outlook.

Bull Confirmed If

An EPS of $2.85 or higher would confirm the bull case and indicate strong operational performance.

Bear Confirmed If

An EPS below $2.70 would confirm the bear case and raise concerns about the company's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±11.87%

Historical Avg

±1.0%

Pricing rich

The options market is pricing in a significant move, indicating that investors expect volatility around the earnings announcement.

Options are pricing ±11.9% while STE has averaged ±1.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

28.7%

Calls (500)P/C Ratio: 11.00Puts (0)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 3.7%, with a raw directional average of -1.4% (modestly negative historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If STERIS beats expectations and raises guidance, history suggests a positive stock reaction, averaging a +0.99% move.

In-Line / Cautious

If results are in line with expectations but management provides cautious commentary, the stock may remain volatile but could stabilize.

Miss

A miss on earnings could lead to a significant decline, with historical data suggesting an average drop of -0.85% following such outcomes.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

1 buy·0 sells

Members

House only

Est. Notional

$1,001.00–$15,000.00

disclosed dollar ranges

Most Active Members

D-MDApril McClain DelaneyRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on operational efficiency improvements.
3Details on market expansion strategies and their potential effects.
4Insights into customer demand trends and how they are being addressed.
5Guidance on future earnings expectations and any changes to long-term goals.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

$2.85

Revenue Growth

Revenue growth reflects the company's ability to increase sales and expand its market presence, which is vital for long-term success.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

STE Q1-2027 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+1.57%

Avg Stock Reaction

-0.34%

Last Quarter Recap

In the last quarter, STERIS reported an EPS of $2.83, slightly missing the estimate of $2.85. The stock reacted negatively, dropping 2.70% the following day.

Management Promises & Guidance

Focus on improving product offerings and customer service.
Commitment to expanding into new markets.
Plans to enhance operational efficiency.

Expectations

Wall Street Expectations

Overall, analysts are cautious ahead of STERIS's earnings report, given the recent EPS miss and mixed market conditions.

Bull Case

If STERIS can show strong revenue growth and improved margins, it could signal a recovery and boost investor confidence.

Bear Case

A continued trend of missing earnings estimates or weak guidance could lead to further declines in stock price.

Key Metrics to Watch

Earnings Per Share (EPS)

$2.85

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

Revenue Growth

N/A

Revenue growth reflects the company's ability to increase sales and expand its market presence, which is vital for long-term success.

Operating Margin

N/A

Operating margin shows how efficiently the company is managing its costs relative to its revenue, an important factor for profitability.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q1-2027?

The EPS figure is crucial for assessing the company's profitability and will heavily influence market sentiment.

How is STERIS addressing recent operational challenges?

Investors will want to know how management plans to improve efficiency and growth, especially after a recent earnings miss.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate STERIS's potential for recovery, given its recent investments in new product lines that could drive future growth.

Supporting Evidence

Options are pricing a significant move, suggesting that investors expect a more volatile reaction than historical averages.

The company's strong track record of innovation could lead to better-than-expected results despite recent challenges.

Key Risk

If STERIS can demonstrate improved operational efficiency and revenue growth, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether STERIS can recover from recent earnings misses and improve its financial outlook.

Bull Confirmed If

An EPS of $2.85 or higher would confirm the bull case and indicate strong operational performance.

Bear Confirmed If

An EPS below $2.70 would confirm the bear case and raise concerns about the company's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±11.87%

Historical Avg

±1.0%

Pricing rich

The options market is pricing in a significant move, indicating that investors expect volatility around the earnings announcement.

Options are pricing ±11.9% while STE has averaged ±1.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

28.7%

Calls (500)P/C Ratio: 11.00Puts (0)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If STERIS beats expectations and raises guidance, history suggests a positive stock reaction, averaging a +0.99% move.

In-Line / Cautious

If results are in line with expectations but management provides cautious commentary, the stock may remain volatile but could stabilize.

Miss

A miss on earnings could lead to a significant decline, with historical data suggesting an average drop of -0.85% following such outcomes.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

1 buy·0 sells

Members

House only

Est. Notional

$1,001.00–$15,000.00

disclosed dollar ranges

Most Active Members

D-MDApril McClain DelaneyRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on operational efficiency improvements.
3Details on market expansion strategies and their potential effects.
4Insights into customer demand trends and how they are being addressed.
5Guidance on future earnings expectations and any changes to long-term goals.